How to Hack a $1.3T Market
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Shares Stats
| Shares Outstanding | 71,900,000 |
| Shares Float | 71,450,000 |
| Shares Short | 1,830,000 |
| Insider Holdings | 61% |
| Institution Holdings | 97.68% |
About West Pharmaceutical Services, Inc
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
General
| Name | West Pharmaceutical Services, Inc |
| Ticker | WST |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 10,600 |
Highlights
| Analyst Target | 314.73 |
| Market Cap | 17,204,600,000 |
| PE Ratio | 35.84 |
| PEG Ratio | 3.46 |
| EBITDA | 789,500,032 |
Financials
| Curr Year EPS Estimate | 6.76 |
| Next Quarter EPS Estimate | 1.61 |
| Profit Margin | 16.48% |
| Operating Margin | 21.12 |
| Return on Assets | 0.11 |
| Return on Equity | 0.18 |
| Revenue | 3B |
| Earnings Per Share | 6.68 |
| Revenue Per Share | 40.83 |
| Gross Profit | 1,044,099,968 |
| Quarterly Revenue Growth | 0.09 |
Valuation
| Trailing PE | 35.82 |
| Forward PE | 37.31 |
| Price/Sales (Trailing 12 Mt.) | 5.81 |
| Price/Book (Most Recent Quarter) | 5.87 |
Dividend
West Pharmaceutical Services, Inc pays out a dividend of $0.54 per share, with a dividend yield of 0.22%.
WST's next dividend payment will be made to shareholders on November 19, 2025.
They pay out 12.27% of their earnings out as a dividend.
Recent Dividends
| Nov 19, 2025 | $0.22 |
| Aug 6, 2025 | $0.21 |
| May 7, 2025 | $0.21 |
| Feb 11, 2025 | $0.21 |
| Nov 20, 2024 | $0.21 |
| Aug 7, 2024 | $0.20 |
| May 1, 2024 | $0.20 |
| Feb 7, 2024 | $0.20 |
| Nov 15, 2023 | $0.20 |
Trump-Backed Spending Bill Forces CPB Shutdown After 60 Years of Public Broadcasting
The Corporation for Public Broadcasting will close after Congress cut $1.1 billion in funding. CPB will shut down by Sept. 30.
Bill Gates Highlights Ugandan Nurse Climbing 1000-Foot Ladders To Deliver Vaccines
Agnes Nambozo, a Ugandan nurse climbs 1,000-foot ladders daily to vaccinate children in remote mountains, said Bill Gates in his blog.
$5 Stock Building Nvidia's AI Servers - Ad
Nuclear stocks gained 51% as energy vampires drain grids . $2B+ revenue, Big Tech pays rent . Massive power opportunity brewing.
What's Going On With Tesla Stock Today?
Tesla stock, after initially trading lower on Friday, has recovered to trade flat midday. The early session dip was in line with broader market weakness following a surprisingly soft U.S. jobs report.
Jim Cramer: This Consumer Defensive Stock Is 'Pretty Expensive'
On CNBC's “Mad Money Lightning Round,” Jim Cramer said that although CoreWeave, Inc. (NASDAQ:CRWV) is good, but Nvidia (NASDAQ:
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
BlackRock's New ETF BILT Bets On $68 Trillion Boom, But Most Investors Are Missing It
BlackRock debuts first actively managed infrastructure ETF (BILT), highlighting growing interest in this sector. Offers diversity and growth potential.
Ukrainian Parliament approves law ensuring independence of anti-graft watchdogs
KYIV, Ukraine (AP) — Ukraine’s Parliament on Thursday overwhelmingly approved a bill presented by President Volodymyr Zelenskyy that of two of the country’s key anti-corruption watchdogs, reversing his last week that curbed their power and brought an outcry.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Economy likely created 115,000 jobs in July as labor market loses momentum
WASHINGTON (AP) — The American job market is deteriorating -- ever so slowly.
Align Technology Stock Tumbles Wednesday: What's Going On?
Align Technology shares are tumbling in Wednesday's after-hours session after the company reported worse-than-expected results for the second quarter and issued soft guidance.
Leaked Memo Reveals AI's Next Land Grab - Ad
The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.
What makes a meme stock? Online enthusiasm for a beaten down company with doubtful prospects
NEW YORK (AP) — Investors occasionally scoop up shares of companies whose financial prospects appear dim. The consensus around such companies is that the shares should, if anything, fall further. But they suddenly get touted in online forums and take off for no fundamental reason. Wall Street has dubbed them “meme stocks.”
Edmunds small luxury SUV test: 2025 Acura ADX vs 2025 BMW X1
The is all-new this year, and it takes its place as Acura’s smallest and least expensive crossover SUV. If you think Acura’s RDX or MDX are too big or too expensive, the entry-level ADX could very well satisfy.
If You Own Tesla Stock, This Might Change Everything - Ad
Jeff Brown, an early Tesla bull, warns of a strange "Tesla Glitch" uncovered by Wall Street legend Larry Benedict. This anomaly has preceded $25B-$100B swings in Tesla's value - and he's using it to anticipate moves without buying or shorting a single share.
Denny's CEO Asks Potential Hires Only Two Questions But Reveals It 'Doesn't Matter What The Questions Are' — Here's Why
Denny's CEO Kelli Valade shares her hiring strategy of looking for red flags and self-awareness through thoughtful questions, not just answers.
Intel CEO Says He's 'Making Hard But Necessary Decisions' As Chipmaker Announces Massive Layoffs, Project Cancellations
Intel is slashing 31% of its workforce and halting global expansion projects in a sweeping restructuring effort as it struggles to compete with AI chip leader Nvidia and regain its edge in the rapidly evolving semiconductor industry.
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
Ranchers say expanding herds to take advantage of record retail beef prices isn't so simple
MINNEAPOLIS (AP) — In a period when retail beef prices are at an all-time high and consumers are still willing to pay, South Dakota rancher Calli Williams would love to cash in. But it's not so simple.
Two pubs claim to be London's oldest riverside pub. Which one is right?
LONDON (AP) — On a charming cobblestone street tucked away in East End, a pub proudly hangs out a sign that reads “Oldest riverside pub in London.” Across the Thames River, a pub with a different name makes the same bold claim.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Why Is Donald Trump Ignoring Elon Musk's Call For 'Phase 2' Of The Epstein Files?
Musk's post questioning Trump's unfulfilled promise of Epstein-related disclosures reignites tensions over transparency in politics and tech.
Embed-Charts-US-Economy-Jobs-Report-July 2025, ADVISORY
US-ECONOMY-JOBS-REPORT-JULY — Charts. The following digital embeds shows the latest reported data of select indicators from the monthly U.S. jobs report. The first embed highlights the monthly unemployment rate, the second shows the monthly job gains and the third charts the labor participation rate. These charts are updated monthly upon release of the report by the Bureau of Labor and Statistics jobs. Source: U.S. Department of Labor.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
Could Trump Accounts Turn American Babies Into Tomorrow's Millionaires? Here's What Experts Say
A new federal savings initiative, known as "Trump accounts," signed into law by President Donald Trump, could significantly alter the financial future of millions of American children.
Draganfly Stock Is Moving Higher Wednesday: What's Going On?
Dragonfly shares are trading higher Wednesday after the company announced its Cammander3 XL UAV has been selected by the Department of Defense for advanced operation initiatives.
Hidden $5 AI Manufacturer Revealed - Ad
The company manufacturing Nvidia's AI servers trades under a secret name. AI revenue: $30B this year. Stock price: $5.
Russia insists on achieving Ukraine goals despite Trump's ultimatum
Russia is open to peace with Ukraine, but achieving its goals remains a priority, Kremlin spokesman Dmitry Peskov said Sunday, days after U.S. President to agree to a ceasefire or .
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Cathie Wood's Ethereum Double-Down: Ark Bets $7.9 Million On ETH-Staking ETF Buy While Selling Coinbase At Highs
On Wednesday, Cathie Wood-led Ark Invest executed significant trades, including substantial purchases in Tempus AI Inc. (NASDAQ:TEM), NVIDIA Corp. (NASDAQ:NVDA), 3iQ Ether Stakin
Trump Is Yet To Sign A Trade Deal With Over 85% Of Humanity — Here Are The Major Countries That Are Yet To Sign
Trump gave a hard deadline for countries that haven't signed a trade deal to start paying tariffs by Aug 1. Most of the world is yet to sign.
$5 Stock Building Nvidia's AI Servers - Ad
Nuclear stocks gained 51% as energy vampires drain grids . $2B+ revenue, Big Tech pays rent . Massive power opportunity brewing.
Colonel Sanders Sold KFC For $2 Million Only To See The New Owners Cash Out For $285 Million Few Years Later — Why He Then Sued Them
Harland Sanders built Kentucky Fried Chicken into a success but sold it for just $2M, feeling sidelined as it grew into a global brand. He died in 1980.
Beef: It's What's for Dinner — If You Can Afford It
Here's a look at why beef is the latest item driving grocery bills higher.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Can Apple's Slim iPhone And Cheaper Macs Reverse The 2025 Stock Slump?
Apple is expected to rebound in the second half of 2025 with new product launches and strong momentum in its Services division. Analysts reaffirmed a Buy rating with a price forecast of $235.
Elizabeth Warren Has The Receipts: 'Bribery In Plain Sight' Funding Trump's Library
Several companies have donated to President Donald Trump's future presidential library. Senator Elizabeth Warren calls this potential "bribery in plain sight."
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
'Buckingham Nicks' was a record store holy grail for decades. It's finally getting reissued
NASHVILLE, Tenn. (AP) — They were in love once.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.